Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirin.

Wang PY, Chen HP, Chen A, Tsay FW, Lai KH, Kao SS, Chen WC, Kuo CH, Peng NJ, Tseng HH, Hsu PI.

Biomed Res Int. 2014;2014:616018. doi: 10.1155/2014/616018. Epub 2014 Aug 27.

2.

[A genetic background of ulcer diseases induced by NSAID/aspirin].

Arisawa T, Tahara T, Nakamura M.

Nihon Rinsho. 2010 Nov;68(11):2113-8. Review. Japanese.

PMID:
21061542
3.

[Genetic polymorphism of COX-1 gene and NSAID-induced ulcer].

Arisawa T, Hirata I.

Nihon Rinsho. 2007 Oct;65(10):1885-9. Review. Japanese.

PMID:
17926541
4.

Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan.

Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H.

Int J Mol Med. 2007 Sep;20(3):373-8.

PMID:
17671743
5.

Aspirin-induced peptic ulcer and genetic polymorphisms.

Shiotani A, Sakakibara T, Nomura M, Yamanaka Y, Nishi R, Imamura H, Tarumi K, Kamada T, Hata J, Haruma K.

J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S31-4. doi: 10.1111/j.1440-1746.2009.06212.x. Review.

PMID:
20586862
6.
7.

The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy.

Shiotani A, Sakakibara T, Yamanaka Y, Nishi R, Imamura H, Fujita M, Tarumi K, Kamada T, Hata J, Haruma K.

J Gastroenterol. 2009;44(7):717-25. doi: 10.1007/s00535-009-0068-0. Epub 2009 May 16.

PMID:
19448967
8.

Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.

Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P.

Scand J Gastroenterol. 2001 Aug;36(8):817-21.

PMID:
11495076
9.

A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.

Piazuelo E, Fuentes J, García-González MA, Jiménez P, Lanas A.

Clin Ther. 2008 Jan;30(1):121-30. doi: 10.1016/j.clinthera.2008.01.020.

PMID:
18343248
10.

Renin-angiotensin system associated with risk of upper GI mucosal injury induced by low dose aspirin: renin angiotensin system genes' polymorphism.

Shiotani A, Nishi R, Yamanaka Y, Murao T, Matsumoto H, Tarumi K, Kamada T, Sakakibara T, Haruma K.

Dig Dis Sci. 2011 Feb;56(2):465-71. doi: 10.1007/s10620-010-1382-3. Epub 2010 Sep 8.

PMID:
20824505
11.

Single nucleotide polymorphism markers for low-dose aspirin-associated peptic ulcer and ulcer bleeding.

Shiotani A, Murao T, Fujita Y, Fujimura Y, Sakakibara T, Nishio K, Haruma K.

J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:47-52. doi: 10.1111/jgh.12770.

PMID:
25521733
12.

Association of SLCO1B1 1b with peptic ulcer amongst Japanese patients taking low-dose aspirin.

Shiotani A, Murao T, Sakakibara T, Tarumi K, Manabe N, Kamada T, Kusunoki H, Haruma K.

Dig Liver Dis. 2012 Mar;44(3):201-5. doi: 10.1016/j.dld.2011.10.005. Epub 2011 Nov 15.

PMID:
22088425
13.

Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases.

Shiroeda H, Tahara T, Shibata T, Nakamura M, Yamada H, Nomura T, Hayashi R, Saito T, Fukuyama T, Otsuka T, Yano H, Ozaki K, Tsuchishima M, Tsutsumi M, Arisawa T.

Int J Mol Med. 2010 Nov;26(5):707-11.

PMID:
20878093
14.

Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.

Liu CP, Chen WC, Lai KH, Mar GY, Lin SY, Ger LP, Hsu PI; Formosa Acid-Related Disease (FARD) Study Group.

Am J Gastroenterol. 2012 Jul;107(7):1022-9. doi: 10.1038/ajg.2012.87. Epub 2012 Apr 17.

PMID:
22508148
15.

Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.

Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.

Aliment Pharmacol Ther. 2004 Nov 15;20(10):1091-7.

16.

MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese.

Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Yamade M, Ikuma M, Sugimura H, Ishizaki T, Hishida A.

Life Sci. 2008 Aug 15;83(7-8):301-4. doi: 10.1016/j.lfs.2008.06.022. Epub 2008 Jul 3.

PMID:
18644389
17.

Association between promoter polymorphisms of nuclear factor-erythroid 2-related factor 2 gene and peptic ulcer diseases.

Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H.

Int J Mol Med. 2007 Dec;20(6):849-53.

PMID:
17982693
18.

Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.

Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK.

Ann Intern Med. 2010 Jan 5;152(1):1-9. doi: 10.7326/0003-4819-152-1-201001050-00179. Epub 2009 Nov 30.

PMID:
19949136
19.

Peptic ulcerations are related to systemic rather than local effects of low-dose aspirin.

van Oijen MG, Dieleman JP, Laheij RJ, Sturkenboom MC, Jansen JB, Verheugt FW.

Clin Gastroenterol Hepatol. 2008 Mar;6(3):309-13. doi: 10.1016/j.cgh.2007.12.018. Epub 2008 Jan 31.

PMID:
18242146
20.

Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system.

Kuyvenhoven JP, Veenendaal RA, Vandenbroucke JP.

Scand J Gastroenterol. 1999 Nov;34(11):1082-6.

PMID:
10582757

Supplemental Content

Support Center